Abstract: Objective To explore the effectiveness of bronchial sleeve lobectomy（BSL）for treating central-type lung cancer. Methods Complications during and after surgery，quality of life and survival rates at 1，3 and 5 years were retrospectively analyzed in 79 patients with central lung cancer，comprising 37 who underwent bronchial sleeve lobectomy（BSL） and 42 who underwent pneumonectomy. Results Postsurgical complications were significantly less frequent in the BLS group（18.9%） than in the pneumonectomy group（40.5%；P＜0.05）. Although the two groups presented similar survival rates at 1 and 3 years，the BLS group showed a significantly higher 5-year survival rate（54.1% vs 42.9%；P＜0.01）. The BLS group also showed significantly lower rates of cancer recurrence（27.0% vs 35.7%；P＜0.0） and cancer metastasis（16.2% vs 42.9%；P＜0.01）. The BLS group scored significantly higher on quality of life（P＜0.05）. Conclusion BSL can reduce the complication rate and increase both quality of life and survival after surgery to treat central-type lung cancer.

Key words: Lung neoplasm, Bronchial sleeve lobectomy, Pneumonectomy, Efficacy